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Abstract
Background: Staphylococcus aureus is the principle causative pathogen of osteomyelitis and implant-associated
bone infections. It is able to invade and to proliferate inside osteoblasts thus avoiding antibiotic therapy and the
host immune system. Therefore, development of alternative approaches to stimulate host innate immune responses
could be beneficial in prophylaxis against S. aureus infection. TLR9 is the intracellular receptor which recognizes
unmethylated bacterial CpG-DNA and activates immune cells. Synthetic CpG-motifs containing
oligodeoxynucleotide (CpG-ODNs) mimics the stimulatory effect of bacterial DNA.
Results: Osteoblast-like SAOS-2 cells were pretreated with CpG-ODN type-A 2216, type-B 2006, or negative CpG-
ODN 2243 (negative control) 4 h before infection with S. aureus isolate EDCC 5055 (=DSM 28763). Intracellular
bacteria were streaked on BHI plates 4 h and 20 h after infection. ODN2216 as well as ODN2006 but not ODN2243
were able to significantly inhibit the intracellular bacterial growth because about 31 % as well as 43 % of
intracellular S. aureus could survive the pretreatment of SAOS-2 cells with ODN2216 or ODN2006 respectively 4 h
and 20 h post-infection. RT-PCR analysis of cDNAs from SAOS-2 cells showed that pretreatment with ODN2216 or
ODN2006 stimulated the expression of TLR9. Pretreatment of SAOS-2 cells with ODN2216 or ODN2006 but not
ODN2243 managed to induce reactive oxygen species (ROS) production inside osteoblasts as measured by flow
cytometry analysis. Moreover, treating SAOS-2 cells with the antioxidant Diphenyleneiodonium (DPI) obviously
reduced S. aureus killing ability of TLR9 agonists mediated by oxidative stress.
Conclusions: In this work we demonstrated for the first time that CPG-ODNs have inhibitory effects on S. aureus
survival inside SAOS-2 osteoblast-like cell line. This effect was attributed to stimulation of TLR9 and subsequent
induction of oxidative stress. Pretreatment of infected SAOS-2 cells with ROS inhibitors resulted in the abolishment
of the CPG-ODNs killing effects.
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Background
S. aureus is the major pathogen causing osteomyelitis
and septic arthritis [1] and highly involved in prosthetic
joint infections following arthroplasty [2]. Moreover, it
was established that S. aureus is able to invade and pro-
liferate inside osteoblasts [3, 4] thus avoiding the host
extracellular antibacterial weapons.
Innate immunity acts as the first active defense line
against infectious pathogens and is responsible for the
control of their early invasion and proliferation inside
the host [5]. One of the largest and most extensively
studied groups of innate immune response receptors are
the Toll-like receptors (TLRs). TLRs are evolutionarily
conserved transmembrane receptors between insects
and vertebrates. They are homologues of the Drosophila
Toll protein and have been established to be important
for defense against microbial infection [6]. TLRs mainly
recognize highly conserved structural motifs known as
pathogen-associated microbial patterns (PAMPs), which
are exclusively expressed by a wide variety of infectious
microorganisms but not by the host. PAMPs include
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various bacterial components such as lipopolysaccharide
(LPS) of Gram-negative bacteria, peptidoglycan (PGN)
and lipopeptides of Gram-positive bacteria, as well as
flagellin, unmethylated bacterial CPG-DNA and viral
double-stranded RNA [7–9].
Stimulation of TLRs by the corresponding PAMPs ini-
tiates signaling cascades leading to the activation of tran-
scription factors, such as AP-1 [10], NF-kB [11] and
interferon regulatory factors (IRFs) [12]. Previous studies
have shown that signaling by TLRs result in a variety of
cellular responses including the production of interferons
(IFNs), pro-inflammatory cytokines and effector cytokines
that direct the adaptive immune response [13, 14].
TLR9 is an intracellular receptor. It recognizes and is
stimulated by unmethylated bacterial CpG-DNA and ini-
tiates potent cellular and humoral immune responses
[13, 15]. Although TLR9 are mainly expressed in im-
mune cells such as dendritic cells, natural killer cells,
monocytes and B cells, it was also detected in osteo-
blasts and its role in modulating the osteoclastogenic ac-
tivity of osteoblasts was reported [16].
The stimulatory effect of bacterial CpG-DNA is due to
the presence of unmethylated CpG dinucleotides in a
particular base context named CpG motif [15]. Bacterial
genomes and vertebrate genomes are different in the fre-
quency and methylation status of CpG dinucleotides.
CpG dinucleotides in bacterial genomes generally occur
at a frequency of about 1/16 as predicted by random
base utilization and are unmethylated. In contrast, CpG
dinucleotides in vertebrate DNA are suppressed to a fre-
quency of only 1/50–60, almost all of which are methyl-
ated [17–19]. CpG-ODNs possess similar stimulatory
effects as bacterial DNA. The CpG-DNA induces B-cell
proliferation and activates cells of the myeloid lineage
such as dendritic cells [15, 20, 21]. Moreover, it has
been recently shown that CpG could mediate peroxide
formation in cultured hepatocytes and dendritic cells
resulting in an enhanced killing of intracellular Salmonella
[22, 23].
Multiple studies have demonstrated that unmethylated
CpG-ODNs have potent immunostimulatory effects in
various immune cell subsets resulting in direct or indir-
ect activation of NK cells, T cells, B cells, monocytes,
macrophages and dendritic cells [23–25]. Based on these
effects, CpG-ODNs act as immune adjuvants that boost
antigen-specific immune responses. These effects are opti-
mized by maintaining close physical contact between the
CpG-ODN and the immunogen [26]. Co-administration
of CpG-ODN with a variety of vaccines has enhanced
humoral and/or cellular immune responses with subse-
quent stimulation of a protective immunity in various
animal models of infectious diseases [27–32]. Moreover,
CpG-ODNs have shown impressive effects as a single
anti-cancer therapeutic agent in different animal tumor
models [33–35] and can increase resistance against acute
non-specific polymicrobial sepsis [36].
However, no published data are currently available
about the effect of CPG-ODNs on the intracellular S.
aureus survival in human osteoblasts. We have recently
shown that intracellular S. aureus survival can be inhib-
ited by antibiotics treatment such as rifampicin. The aim
of the current study was to show the impact of CpG-
ODNs on the expression of TLR9 in osteoblasts and if
they have an inhibitory effect on the intracellular sur-
vival of S. aureus inside osteoblasts. Moreover, the
mechanism of action of CpG-ODNs on the intracellular
S. aureus will be demonstrated.
Methods
Bacteria
Bacterial strain used in this study is S. aureus isolate
EDCC 5055 (available at DSMZ; number “DSM 28763”)
[4, 37]. Bacteria were grown in brain-heart infusion
(BHI) broth. In all experiments, fresh cultures of bac-
teria, prepared from an overnight culture, were used.
Briefly, bacteria were grown in Brain Heart Infusion
(BHI) at 37 °C, harvested in the exponential growth
phase and washed twice with phosphate buffer saline
(PBS). The pellet was resuspended in PBS and the bac-
terial concentration was calibrated by optical absorption.
Further dilutions were prepared in PBS to obtain re-
quired numbers of bacteria for infection. Hemolytic ac-
tivity was determined as described [37, 38].
Biofilm formation testing of S. aureus EDCC 5055 was
based on the ability of the bacteria to form biofilms on
polystyrene (PS) plastic, e.g. the development of micro-
colonies that can be detected macroscopically. Biofilm
formation assay was performed as described [39]. Briefly,
overnight cultures in TSB were diluted 1:100 into fresh
medium and 200 μl of the freshly inoculated medium
was dispensed into the wells of a microtiter plate. The
inoculated microtiter plate was incubated at 37 °C for
48 h without agitation. The liquid cultures were re-
moved and the wells were rinsed twice thoroughly and
vigorously with biofilm buffer (2 mM CaCl2/MgCl2) to
remove unattached cells. Two hundred microliter of bio-
film buffer and 20 μl of CV staining solution (0.1 % w/v
crystal violet in water) were added to detect biofilms by
staining. The plates were incubated for 15 min at room
temperature and then rinsed with biofilm buffer to re-
move residual staining. Bacteria able to form biofilms
coated the inner surface of the wells and the microcolo-
nies were visible in purple colour.
ODNs
ODN2216 (InvivoGen) is an A-class CpG ODN with a
preference for human TLR9 characterized by a phospho-
diester central CpG-containing palindromic motif and a
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phosphorothioate 3’ poly-G string. A-class CpG ODN
mainly stimulates and induces secretion of IFN-α from
plasmacytoid dendritic cells [40].
ODN2006 (InvivoGen) is a CpG ODN class B specific
for human TLR9. It contains a full phosphorothioate
backbone with one or more CpG dinucleotides. B-class
CpG ODN is a strong stimulator for B-cells [41].
ODN2243 (InvivoGen) is designed as a negative con-
trol. ODN2243 contains GpC dinucleotides instead of
CpGs and does not induce TLR9 activity [42].
In vitro invasion assay of SAOS-2 cells
SAOS-2 osteoblast-like cell line was grown in Gibco
Minimum Essential Medium (MEM) (Life technologies)
supplemented with 10 % fetal calf serum (FCS) and 1 %
non-essential amino acids. For infection assay, SAOS-2
cells were cultured to a semi confluent layer (2x105
cells/ml) in 24-well plates. Cells were treated with
ODN2216, ODN2006, or ODN2243 (250 nM) (InvivoGen)
4 h prior to infection with S. aureus. 10 μM diphenyleneio-
donium chloride (DPI) (Sigma-Aldrich) was added to
ODN-pretreated cells 1 h prior to infection in order to con-
firm the role of oxidative stress in S. aureus intracellular
survival. Bacterial cultures were incubated overnight.
Following 1:10 fresh media dilution, bacterial cultures were
grown for 2 h and diluted to an OD of 0.1 with MEM
medium. Bacteria were added at a multiplicity of infection
(MOI) of 30 per well. After incubation for 30 min, super-
natant was discarded and infected cells were washed twice
with 1x PBS. MEM was replaced by medium supplemented
with 30 μg/ml gentamicin to kill only the remaining extra-
cellular bacteria without affecting the intracellular bacteria
[43]. Cells were then incubated at 37 °C for 2, 4, 6 and 24 h.
The supernatant fluids were discarded and the cells were
washed three times with 1x PBS and lysed with 0.2 %
Triton X-100 in sterile cold distilled water for 20 min after
this cells were thoroughly mixed to achieve complete lysis.
The lysates were diluted 10 times in 1x PBS and plated
onto BHI agar plates using the Auto plate 3000 spiral plat-
ing system (Spiral Biotech, USA). After 24 h of incubation
at 37 °C, the number of bacterial colonies were counted
and the total colony forming units (cfu) were determined.
In order to determine the expression of TLR9 and induc-
tion of oxidative stress in SAOS-2 cells, cells were treated
with ODN2216, ODN2006, ODN2243 (250 nM) or left un-
treated 4 h prior to lysis for RNA isolation or collection for
flow cytometry analysis.
RNA isolation
SAOS-2 cells from three wells of a six well tissue culture
plaque were lysed using RLT lysis buffer (Qiagen) after
aspiration of the MEM medium. Total RNA was isolated
using the RNeasy Mini Kit and the RNase free DNase I set
(Qiagen) following the manufacturers protocol. The RNA
was recovered in RNase free water, heat denatured for
10 min. at 65 °C; quantified with the NanoDrop® ND-1000
UV–vis Spectrophotometer (NanoDrop Technologies)
and a quality profile with the Agilent 2100 bioanalyzer
(Agilent Technologies) was made.
Real time RT-PCR
First-strand cDNA was synthesized from 500 ng of puri-
fied RNA using SuperScriptII (Invitrogen) and a mixture
of T21 and random nonamer primers (Metabion) follow-
ing the instructions for the reverse transcription reaction
recommended for the QuantiTect SYBR Green PCR Kit
(Qiagen). Real-time quantitative PCR was performed on
an ABI Prism 7700 real time cycler using human TLR9
primers (Qiagen). Human ACTB primer pair (Qiagen)
was used as a positive control. The PCR products under-
went agarose gel electrophoresis.
Measurement of oxidative stress by flow cytometry
SAOS-2 cells pretreated with ODNs were detached from
cell culture plates. To detect ROS formation, we stained
the cells for 30 min with the fluorescent reporter dye 3′-
(p-hydroxyphenyl) fluorescein (HPF, Invitrogen) at a
concentration of 5 μM at room temperature. Cells were
washed twice with PBS to remove excess HPF and sus-
pended in PBS supplemented with 1 % FCS. Flow
cytometry was performed using a FACS Calibur flow
cytometer and further analysed with CELL Quest soft-
ware (Becton Dickinson).
Statistical analysis
Data are representative of at least three independent ex-
periments. Significance of the represented data was
calculated using unpaired Student’s t test. Data are
expressed as mean ± standard errors.
Results
CpG-ODNs control survival of S. aureus inside osteoblasts
S. aureus EDCC5055 has been previously shown to suc-
cessfully invade and proliferate inside SAOS-2 cells
where bacteria could successfully survive inside osteo-
blasts during the first 6 h after infection. However, intra-
cellular bacterial survival was dramatically reduced 20 h
after infection in comparison to 4 h post-infection due
to induction of apoptosis in SAOS-2 cells thus exposing
the intracellular bacteria to the action of the extracellu-
lar gentamicin [4]. In this study, pretreatment of SAOS-
2 cells with ODN2216 or ODN2006 could clearly inhibit
intracellular survival of S. aureus as the number of intra-
cellular bacteria was significantly reduced 4 h post infec-
tion. This inhibitory effect could be also observed 20 h
post infection. Pretreatment of SAOS-2 cells with
ODN2243 did not show any obvious reduction in
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intracellular survival of S. aureus either 4 h or 20 h post-
infection in comparison to untreated cells (Fig. 1).
CpG-ODNs induce TLR9 expression in SAOS-2 cells
TLR9 is normally expressed by various immune cells
such as dendritic cells, B lymphocytes, monocytes and
natural killer (NK) cells but could also be expressed by
epithelial non-phagocytic cells such as osteoblasts [16].
Using quantitative RT-PCR for cDNAs generated from
RNAs of SAOS-2 cells which were pretreated with dif-
ferent CpG-ODNs, we could show that expression of
TLR9 in SAOS-2 osteoblast-like cells was upregulated
following treatment with ODN2216 and ODN2006 while
pretreatment of SAOS-2 cells with ODN2243 was not
able to stimulate TLR9 expression as shown by agarose
gel electrophoresis (Fig. 2). β-Actin (ACTB) showed the
same expression quantity under all conditions.
CpG-ODNs enhance TLR9-mediated oxidative stress in
SAOS-2 cells
In order to explain the mechanism of intracellular bac-
terial killing in SAOS-2 cells following treatment with
ODN2216 and ODN2006, induction of oxidative stress
inside osteoblasts was examined after treatment with
different ODNs. Pretreatment of SAOS-2 cells with
ODN2216 or ODN2006 managed to induce ROS pro-
duction inside osteoblasts as shown by flow cytometry
through shift in fluorescence of HPF-stained SAOS-2
cells (Fig. 3) while pretreatment with ODN2243 as well
as ODN-untreated cells did not show any enhancement
of ROS production by SAOS-2 cells. Failure of
ODN2243 to induce ROS production inside osteoblasts
confirms the involvement of TLR9 stimulation in oxida-
tive stress induction inside SAOS-2 cells. Diphenyleneio-
donium (DPI) has frequently been used to inhibit ROS
production mediated by flavoenzymes, particularly
NADPH oxidase [44]. Treating SAOS-2 cells with the
antioxidant DPI obviously reduced S. aureus killing abil-
ity of the TLR9 agonist, CpG-ODN2216, because sur-
vival of intracellular S. aureus has significantly increased
4 h and 20 h after infection in SAOS-2 cells pretreated
with both ODN2216 and DPI in comparison to
Fig. 1 CpG-ODNs inhibit intracellular growth of S. aureus in SAOS-2 osteoblast-like cell line. SAOS-2 cells were pretreated with 250 nM of ODN2216,
ODN2006, or ODN2243 4 h before infection or left untreated. Bacteria infected osteoblasts at a MOI of 30 for 30 min after which gentamicin (30 μg/ml)
was added and intracellular bacterial growth was monitored at 4 h and 20 h post-infection (**P < 0, 05; *P < 0, 10)
Fig. 2 CpG-ODNs induce the expression of TLR9 in SAOS-2 cells. SAOS-2
cells were treated for 4 h with 250 nM of ODN2216 (1), ODN2006 (2),
ODN2243 (3) or left untreated (4). cDNA was synthetized from isolated
SAOS-2 RNA and underwent real-time quantitative PCR using human
TLR9 or ACTB primers. PCR products were analyzed on 1 % agarose gel
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treatment with ODN2216 alone indicating that intracel-
lular S. aureus was killed throughTLR9-mediated oxida-
tive stress (Fig. 4).
Treatment of SAOS-2 cells with only DPI without
CpG-ODN did not affect the intracellular survival of
S. aureus as bacteria could grow at a level equal to
that shown in untreated SAOS-2 cells.
Discussion
S. aureus infections are considered not only the most
serious cause of implant, prosthetic device and intravas-
cular line infection but also the most common cause of
hospitalization for surgical drainage of pus in children or
treatment of bacteremia in elderly [45–47]. Elevated
levels of mortality, morbidity, and costs resulting from
invasive S. aureus infections despite the introduction of
several new antibiotics encouraged investigators to
develop effective alternative interventional strategies to
control these infections [47, 48]. Passive immunotherapy
with anti S. aureus glucosaminidase monoclonal antibody
has recently shown promising treatment potential in
mouse model of implant-associated osteomyelitis [49].
During infection bacterial DNA is released and ex-
poses host cells that express TLR9 to the unmethylated
CpG motifs, thus stimulating a protective immune re-
sponse against the invading pathogen [13, 15]. The
immunostimulatory activity of bacterial DNA is mim-
icked by CpG-ODNs [50]. After internalization by target
cells, CpG-ODNs reach the late endosomal/lysosomal
compartment where they signal by interacting with
TLR9 [51]. TLR9 knockout mice do not respond to
stimulation by CpG-ODNs [13].
Osteoblasts have been recently shown to express TLR9
receptors that are able to transmit cellular signaling and
induce osteoblasts osteoclstogenic activity [16]. S. aureus
can invade and proliferate inside osteoblasts [3, 4] thus
remains protected from extracellular immune responses
such as antibodies, cationic peptides and recognition by
phagocytic cells in addition to antibiotics. This evasion
strategy plays a crucial role in recurrence and persist-
ence of S. aureus infection. Therefore, stimulation of
host innate immune responses could be an efficient
approach in prophylaxis against S. aureus infection.
In this study we have shown for the first time that syn-
thetic CpG-ODNs could significantly inhibit S. aureus
Fig. 4 The antioxidant DPI reduces the intracellular growth inhibitory effect of ODNs on S. aureus. SAOS-2 cells were pretreated with 250 nM of ODN2216
4 h and/or with 10 μM of DPI 1 h before infection or left untreated. Bacteria infected osteoblasts as described in Fig. 1 (**P< 0, 05; *P< 0, 10)
Fig. 3 CpG-ODNs stimulate production of ROS by SAOS-2 cells. SAOS-2
cells were treated for 4 h with 250 nM of ODN2216, ODN2006, ODN2243
(Neg. ODN) or left untreated. Cells were then stained with the ROS
indicator, HPF. Binding of HPF to SAOS-2 cells was analysed by
flow cytometry
Mohamed et al. BMC Microbiology  (2016) 16:230 Page 5 of 8
intracellular survival inside SAOS-2 cells, an effect
which negative CpG-ODN was not able to show. CpG-
ODNs could induce expression of TLR9 in SAOS-2 cells
indicating that intracellular bacterial killing effect of
CpG-ODNs could be mediated by TLR9.
During the initial stages of infection by S. aureus,
phagocytes including neutrophils and macrophages are
recruited to the site of infection and engulf the pathogen
with subsequent killing in the phagolysosome by produc-
tion of lysosomal enzymes and ROS [52]. In fact, pro-
duction of ROS is a common antibacterial mechanism
elicited by professional antigen presenting cells in order
to kill engulfed bacteria in the intracellular compart-
ments [53]. Patients who are neutropenic or have con-
genital or acquired defects in polymorphonuclear
neutrophils (PMNs) function are more susceptible to S.
aureus infection [54]. The NADH-dependent phagocytic
oxidase produces superoxide, which upon dismutation
forms hydrogen peroxide. Both superoxide anions and
hydrogen peroxide can damage a variety of biomolecules
including DNA, proteins, and lipids. Moreover, these
species can destroy iron-sulfur clusters with subsequent
release of iron which can undergo a Fenton reaction
with hydrogen peroxide to yield hydroxyl radical which
damages any biological molecule in a diffusion limited
manner [55]. Anti-oxidant enzymes such as superoxide
dismutase and catalase form part of a defense mechan-
ism that helps S. aureus to protect itself from oxygen
toxicity [44].
We have previously shown that intracellular S. aureus
were surrounded by phagosomal/lysosomal membranes
inside SAOS-2 cells [4], indicating that intracellular S.
aureus could be exposed to the action of ROS inside
osteoblasts. Our flow cytometry analysis revealed that
CpG-ODNs stimulated ROS production by SAOS-2
cells. ROS were able to inhibit intracellular survival of S.
aureus inside osteoblasts because pretreatment of
SAOS-2 cells with the antioxidant, DPI could signifi-
cantly restore the intracellular growth of S. aureus. Our
study, in combination with our own previous work and
the results of other groups on implant infections, shed
light on a complex interplay of S. aureus at the interface
of implant surface and host tissue. The pathogen, able to
form a biofilm on implant surfaces, induces potentially
an implant-associated infection and is capable of
occasionally releasing planktonic cells thus causing
bacteremia or even sepsis. Apart from its capacity to
form biofilms, S. aureus is able to invade the sur-
rounding tissue which constitutes a niche to escape
the attack of the immune system and circulating anti-
biotics. CpG-ODNs, as shown for the first time in
this study, exhibit a new weapon to prevent the nid-
ation of S. aureus in the surrounding tissue and oste-
oblasts. A pre-clinical trial in goats showed promising
effects of CpG-ODN against mastitis caused by E. coli
infection. It induced the expression of TLR9 mRNA
in mammary tissue and reduced bacterial count in
milk [56].
Fig. 5 A schematic representation for the pretreatment of SAOS-2 cells by CpG-ODNs prior to infection with S. aureus. CpG-ODNs were internalized into
the endosomal vesicles that contain TLR9. Recognition of CpG-ODNs by TLR9 upregulates the expression of TLR9 which in turn mediates formation of ROS
by NADPH oxidase leading to killing the intracellular S. aureus by oxidative stress . Pretreating SAOS-2 cells with Diphenyleneiodonium (DPI), a potent
NADPH Oxidase inhibitor, restored the intracellular survival of S. aureus
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In addition, ongoing clinical studies indicate that CpG-
ODNs are safe and well-tolerated when administered as a
monotherapy or as adjuvants to humans [57, 58]. In this
work, it was revealed that a single administration of
CPG-ODNs can induce oxidative stress through
stimulation of TLR9 in epithelial non-phagocytic cells
(Fig. 5) thus mounting innate immunity against invad-
ing infectious pathogens.
Conclusions
In this study, CpG-ODNs could show promising effects
against intracellular S. aureus. They managed to induce
the expression of TLR9 in SAOS-2 cells with subsequent
production of ROS leading to killing of intracellular S.
aureus. Pretreatment of the infected SAOS-2 cells with
DPI could restore the intracellular survival of S. aureus.
Therefore, CpG-ODNs are promising new tools to
support interruption of the interplay of S. aureus at the
interface of implant devices and surrounding tissue.
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